Overview

A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This study will examine the safety and efficacy of albiglutide in combination with insulin glargine as compared with the combination of insulin glargine and preprandial lispro insulin in subjects with type 2 diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Glucagon-Like Peptide 1
Insulin
Insulin Glargine
Insulin Lispro
Insulin, Globin Zinc
rGLP-1 protein